• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Xenon Pharmaceuticals Inc. - Common Shares (NQ:XENE)

    58.83 -0.52 (-0.88%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 937,429
    Open 59.70
    Bid (Size) 58.78 (1,000)
    Ask (Size) 58.88 (4,200)
    Prev. Close 59.35
    Today's Range 58.35 - 59.70
    52wk Range 28.19 - 63.95
    Shares Outstanding 63,562,303
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Xenon to Present at Upcoming Investor Conferences
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire

    Performance

    YTD
    +32.2%
    +32.2%
    1 Month
    +7.6%
    +7.6%
    3 Month
    +41.5%
    +41.5%
    6 Month
    +40.4%
    +40.4%
    1 Year
    +78.1%
    +78.1%

    More News

    Read More
    News headline image
    Xenon Pharma Stock Up 55% as Insider Sells $78K in Shares. Here's What Investors Should Know ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    XENON PHARMACEUTICALS INC (NASDAQ:XENE) Reports Q4 and Full-Year 2025 Results, Focus Remains on Upcoming Phase 3 Data for Azetukalner ↗
    Via Chartmill
    News headline image
    This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Battery Storage Stock Up 50% in a Year Draws New $110M Investment. Here's What You Should Know ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)
    Via Finterra
    Topics ETFs Intellectual Property
    News headline image
    Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    The Potassium Channel Breakthrough: A Deep-Dive on Xenon Pharmaceuticals (XENE)
    Via Finterra
    Topics Economy Initial Public Offering Intellectual Property
    News headline image
    XENE Stock Rallies 50% On Epilepsy Trial Data, But One Analyst Thinks Rival Biohaven Still Has ‘Room To Differentiate’ ↗
    Via Stocktwits
    News headline image
    Xenon Pharmaceuticals Announces Proposed Public Offering
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    Top stock movements in today's session. ↗
    Via Chartmill
    Monday's session: top gainers and losers ↗
    Via Chartmill
    Gapping stocks in Monday's session ↗
    Via Chartmill
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS)
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update
    From Xenon Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer ↗
    Via The Motley Fool
    News headline image
    Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Spyre Therapeutics Stock Surges This Past Year as $10.5 Million Buy Lifts Stake to $78 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50% ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29% ↗
    Via The Motley Fool
    Topics Regulatory Compliance

    Frequently Asked Questions

    Is Xenon Pharmaceuticals Inc. - Common Shares publicly traded?
    Yes, Xenon Pharmaceuticals Inc. - Common Shares is publicly traded.
    What exchange does Xenon Pharmaceuticals Inc. - Common Shares trade on?
    Xenon Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares?
    The ticker symbol for Xenon Pharmaceuticals Inc. - Common Shares is XENE on the Nasdaq Stock Market
    What is the current price of Xenon Pharmaceuticals Inc. - Common Shares?
    The current price of Xenon Pharmaceuticals Inc. - Common Shares is 58.83
    When was Xenon Pharmaceuticals Inc. - Common Shares last traded?
    The last trade of Xenon Pharmaceuticals Inc. - Common Shares was at 04/15/26 04:00 PM ET
    What is the market capitalization of Xenon Pharmaceuticals Inc. - Common Shares?
    The market capitalization of Xenon Pharmaceuticals Inc. - Common Shares is 3.74B
    How many shares of Xenon Pharmaceuticals Inc. - Common Shares are outstanding?
    Xenon Pharmaceuticals Inc. - Common Shares has 4B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.